Exactly. No, I want.... Since it's their information, I have to talk to them first, but I commit to the committee that, after I leave, I will talk to them and see what they're willing to make available to the committee.
To your question on Medicago, you know Medicago is a challenging situation. I have three objectives: maintaining jobs, maintaining IP and trying to keep the company as a going concern. What we have been talking with the CEO of Mitsubishi in Japan about was really to achieve that.
At the time when we invested in Medicago—and I know that now people can look back and say that maybe we should have and maybe we shouldn't have—we wanted to invest in the five families of vaccines, because no one knew which would one would work. Actually, for Medicago, when you talk to the WHO, they will tell you that plant-based vaccines have a lot of potential to be able to cure future pandemics we could have.
My main mission to you, sir, today is to protect the IP and keep that in Canada, using our contractual provision that we have to lock the IP in Canada. That's what I'm doing.
That's why, to go back to Volkswagen, I like to do that in a contract, because a contract gives the government far more tools when we want to do certain things than if you just do it like the United States, for example, with the tax credit. That, I think, is the smart answer of Canada to the IRA.